HomeCHM • ASX
add
Chimeric Therapeutics Ltd
Nakaraang pagsara
$0.014
Sakop ng araw
$0.014 - $0.015
Sakop ng taon
$0.013 - $0.047
Market cap
17.74M AUD
Average na Volume
1.23M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
TipRanks
4 oras ang nakalipas
China Discourages Local Companies from Buying Nvidia (NASDAQ:NVDA) Chips
2.17%
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | -1.76M | -348.85% |
Gastos sa pagpapatakbo | 5.28M | -28.45% |
Net na kita | -7.49M | -5.68% |
Net profit margin | 426.27 | 142.47% |
Kita sa bawat share | — | — |
EBITDA | -6.77M | -5.43% |
Aktuwal na % ng binabayarang buwis | -0.55% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.05M | -43.14% |
Kabuuang asset | 15.27M | -31.74% |
Kabuuang sagutin | 12.80M | -23.40% |
Kabuuang equity | 2.47M | — |
Natitirang share | 876.06M | — |
Presyo para makapag-book | ∞ | — |
Return on assets | -115.10% | — |
Return on capital | -711.67% | — |
Cash Flow
Net change in cash
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -7.49M | -5.68% |
Cash mula sa mga operasyon | -1.43M | 21.26% |
Cash mula sa pag-invest | -11.72K | 81.66% |
Cash mula sa financing | 1.19M | -4.10% |
Net change in cash | -236.20K | 62.61% |
Malayang cash flow | -4.17M | -17.06% |
Tungkol
Itinatag
2020
Website
